In situ binding of fatty acids to the liver fatty acid binding protein: analysis using 3-[125I]iodo-4-azido-n-hexadecylsalicylamide

David W. Waggoner; Joan A. Manning; Nathan M. Bass; David A. Bernlohr

doi:10.1016/S0006-291X(05)81308-7

In situ binding of fatty acids to the liver fatty acid binding protein: analysis using 3-[¹²⁵I]iodo-4-azido-n-hexadecylsalicylamide

David W. Waggoner, Joan A. Manning, Nathan M. Bass, David A. Bernlohr

Metabolic and Systems Biology (BMBB)

Research output: Contribution to journal › Article › peer-review

21 Scopus citations

Abstract

A photoactivatable radioiodinated fatty acid analogue, 3-[¹²⁵I]iodo-4-azido-N-hexadecylsalicylamide (¹²⁵I-AHS) has been synthesized and used to investigate the involvement of cellular lipid carriers in hepatic fatty acid utilization. Photoactivation of Hep G2 internalized ¹²⁵I-AHS revealed that several cellular proteins were crosslinked with the radiolabeled fatty acid analogue. Three predominant proteins in the membrane fraction of the cell with molecular masses 17, 50 and 127 kDa were crosslinked with the lipid analogue, as determined using autoradiography after SDS-PAGE. Three other proteins in the soluble fraction of the cell, with molecular masses 14, 24 and 35 kDa, were also labeled in situ. In contrast to the other labeled proteins, the fatty acid analogue accumulated on the cytoplasmic 14 kDa protein in a time and temperature dependent fashion. The in situ-labeled 14 kDa protein was identified from primary rat hepatocytes as the liver fatty acid binding protein by partial purification and its ability to be immunoprecipitated with immunospecific L-FABP antiserum. Collectively the results indicate that fatty acids traverse the plasma membrane and are bound cytoplasmically by the liver fatty acid binding protein, as well as other proteins in the cell. This represents the first demonstration in intact hepatocytes that the liver fatty acid binding protein participates in the process of intracellular fatty acid trafficking, and supports a model in which cytoplasmic lipid carriers solublize fatty acids as a step in their metabolic utilization.

Original language	English (US)
Pages (from-to)	407-415
Number of pages	9
Journal	Biochemical and Biophysical Research Communications
Volume	180
Issue number	1
DOIs	https://doi.org/10.1016/S0006-291X(05)81308-7
State	Published - Oct 15 1991

Bibliographical note

Funding Information:
We wish to thank Tom Krick for his expert technical assistance with the gas chromatographic and mass spectral analysis of AHS. We also thank Dr. Harvey Sharp and Kathy Cleary (Department of Pediatrics, University of Minnesota Medical School) for providing the primary rat hepatocytes, and Dr. Clifford Steere (Department of Medicine, University of Minnesota Medical School) for providing Hep G2 cells. This work was supported in part by NIH grants P30-DK3493t andDK32926 to N.M.B. and

Funding Information:
grants from the American Diabetes Association and the National Science Foundation (DMB 8552942) to D.A.B.

Keywords

4-azidohexadecyl salicylamide
AHS
ALBP
CoA
DMEM
Dulbecco's modified Eagle's medium
EDTA
FABP
FAS
PAGE
PMSF
SDS
adipocyte lipid binding protein
coenzyme A
ethylene diaminetetraacetic acid
fatty acid binding protein
fatty acid synthase
phenylmethylsulfonylfluoride
polyacrylamide gel electrophoresis
sodium dodecyl sulfate

Access

10.1016/S0006-291X(05)81308-7

OpenUrl availability

Full text

Cite this

@article{45f105ed08c342aeb276bb5ac8c661af,

title = "In situ binding of fatty acids to the liver fatty acid binding protein: analysis using 3-[125I]iodo-4-azido-n-hexadecylsalicylamide",

abstract = "A photoactivatable radioiodinated fatty acid analogue, 3-[125I]iodo-4-azido-N-hexadecylsalicylamide (125I-AHS) has been synthesized and used to investigate the involvement of cellular lipid carriers in hepatic fatty acid utilization. Photoactivation of Hep G2 internalized 125I-AHS revealed that several cellular proteins were crosslinked with the radiolabeled fatty acid analogue. Three predominant proteins in the membrane fraction of the cell with molecular masses 17, 50 and 127 kDa were crosslinked with the lipid analogue, as determined using autoradiography after SDS-PAGE. Three other proteins in the soluble fraction of the cell, with molecular masses 14, 24 and 35 kDa, were also labeled in situ. In contrast to the other labeled proteins, the fatty acid analogue accumulated on the cytoplasmic 14 kDa protein in a time and temperature dependent fashion. The in situ-labeled 14 kDa protein was identified from primary rat hepatocytes as the liver fatty acid binding protein by partial purification and its ability to be immunoprecipitated with immunospecific L-FABP antiserum. Collectively the results indicate that fatty acids traverse the plasma membrane and are bound cytoplasmically by the liver fatty acid binding protein, as well as other proteins in the cell. This represents the first demonstration in intact hepatocytes that the liver fatty acid binding protein participates in the process of intracellular fatty acid trafficking, and supports a model in which cytoplasmic lipid carriers solublize fatty acids as a step in their metabolic utilization.",

keywords = "4-azidohexadecyl salicylamide, AHS, ALBP, CoA, DMEM, Dulbecco's modified Eagle's medium, EDTA, FABP, FAS, PAGE, PMSF, SDS, adipocyte lipid binding protein, coenzyme A, ethylene diaminetetraacetic acid, fatty acid binding protein, fatty acid synthase, phenylmethylsulfonylfluoride, polyacrylamide gel electrophoresis, sodium dodecyl sulfate",

author = "Waggoner, {David W.} and Manning, {Joan A.} and Bass, {Nathan M.} and Bernlohr, {David A.}",

note = "Funding Information: We wish to thank Tom Krick for his expert technical assistance with the gas chromatographic and mass spectral analysis of AHS. We also thank Dr. Harvey Sharp and Kathy Cleary (Department of Pediatrics, University of Minnesota Medical School) for providing the primary rat hepatocytes, and Dr. Clifford Steere (Department of Medicine, University of Minnesota Medical School) for providing Hep G2 cells. This work was supported in part by NIH grants P30-DK3493t andDK32926 to N.M.B. and Funding Information: grants from the American Diabetes Association and the National Science Foundation (DMB 8552942) to D.A.B.",

year = "1991",

month = oct,

day = "15",

doi = "10.1016/S0006-291X(05)81308-7",

language = "English (US)",

volume = "180",

pages = "407--415",

journal = "Biochemical and Biophysical Research Communications",

issn = "0006-291X",

publisher = "Academic Press Inc.",

number = "1",

}

TY - JOUR

T1 - In situ binding of fatty acids to the liver fatty acid binding protein

T2 - analysis using 3-[125I]iodo-4-azido-n-hexadecylsalicylamide

AU - Waggoner, David W.

AU - Manning, Joan A.

AU - Bass, Nathan M.

AU - Bernlohr, David A.

N1 - Funding Information: We wish to thank Tom Krick for his expert technical assistance with the gas chromatographic and mass spectral analysis of AHS. We also thank Dr. Harvey Sharp and Kathy Cleary (Department of Pediatrics, University of Minnesota Medical School) for providing the primary rat hepatocytes, and Dr. Clifford Steere (Department of Medicine, University of Minnesota Medical School) for providing Hep G2 cells. This work was supported in part by NIH grants P30-DK3493t andDK32926 to N.M.B. and Funding Information: grants from the American Diabetes Association and the National Science Foundation (DMB 8552942) to D.A.B.

PY - 1991/10/15

Y1 - 1991/10/15

N2 - A photoactivatable radioiodinated fatty acid analogue, 3-[125I]iodo-4-azido-N-hexadecylsalicylamide (125I-AHS) has been synthesized and used to investigate the involvement of cellular lipid carriers in hepatic fatty acid utilization. Photoactivation of Hep G2 internalized 125I-AHS revealed that several cellular proteins were crosslinked with the radiolabeled fatty acid analogue. Three predominant proteins in the membrane fraction of the cell with molecular masses 17, 50 and 127 kDa were crosslinked with the lipid analogue, as determined using autoradiography after SDS-PAGE. Three other proteins in the soluble fraction of the cell, with molecular masses 14, 24 and 35 kDa, were also labeled in situ. In contrast to the other labeled proteins, the fatty acid analogue accumulated on the cytoplasmic 14 kDa protein in a time and temperature dependent fashion. The in situ-labeled 14 kDa protein was identified from primary rat hepatocytes as the liver fatty acid binding protein by partial purification and its ability to be immunoprecipitated with immunospecific L-FABP antiserum. Collectively the results indicate that fatty acids traverse the plasma membrane and are bound cytoplasmically by the liver fatty acid binding protein, as well as other proteins in the cell. This represents the first demonstration in intact hepatocytes that the liver fatty acid binding protein participates in the process of intracellular fatty acid trafficking, and supports a model in which cytoplasmic lipid carriers solublize fatty acids as a step in their metabolic utilization.

AB - A photoactivatable radioiodinated fatty acid analogue, 3-[125I]iodo-4-azido-N-hexadecylsalicylamide (125I-AHS) has been synthesized and used to investigate the involvement of cellular lipid carriers in hepatic fatty acid utilization. Photoactivation of Hep G2 internalized 125I-AHS revealed that several cellular proteins were crosslinked with the radiolabeled fatty acid analogue. Three predominant proteins in the membrane fraction of the cell with molecular masses 17, 50 and 127 kDa were crosslinked with the lipid analogue, as determined using autoradiography after SDS-PAGE. Three other proteins in the soluble fraction of the cell, with molecular masses 14, 24 and 35 kDa, were also labeled in situ. In contrast to the other labeled proteins, the fatty acid analogue accumulated on the cytoplasmic 14 kDa protein in a time and temperature dependent fashion. The in situ-labeled 14 kDa protein was identified from primary rat hepatocytes as the liver fatty acid binding protein by partial purification and its ability to be immunoprecipitated with immunospecific L-FABP antiserum. Collectively the results indicate that fatty acids traverse the plasma membrane and are bound cytoplasmically by the liver fatty acid binding protein, as well as other proteins in the cell. This represents the first demonstration in intact hepatocytes that the liver fatty acid binding protein participates in the process of intracellular fatty acid trafficking, and supports a model in which cytoplasmic lipid carriers solublize fatty acids as a step in their metabolic utilization.

KW - 4-azidohexadecyl salicylamide

KW - AHS

KW - ALBP

KW - CoA

KW - DMEM

KW - Dulbecco's modified Eagle's medium

KW - EDTA

KW - FABP

KW - FAS

KW - PAGE

KW - PMSF

KW - SDS

KW - adipocyte lipid binding protein

KW - coenzyme A

KW - ethylene diaminetetraacetic acid

KW - fatty acid binding protein

KW - fatty acid synthase

KW - phenylmethylsulfonylfluoride

KW - polyacrylamide gel electrophoresis

KW - sodium dodecyl sulfate

UR - http://www.scopus.com/inward/record.url?scp=0025935742&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025935742&partnerID=8YFLogxK

U2 - 10.1016/S0006-291X(05)81308-7

DO - 10.1016/S0006-291X(05)81308-7

M3 - Article

C2 - 1930234

AN - SCOPUS:0025935742

SN - 0006-291X

VL - 180

SP - 407

EP - 415

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

IS - 1

ER -